TLN the next Exelixis
https://www.fool.com/investing/general/2009/04/07/bristol-myers-squibb-on-the-patent-cliffs-edge.aspx
Pharmas are buying / signing licensing deals with smaller players to replenish pipeline. That's a fact.
Thallion fits into that Trend.
Pepmoron has conistenly been loosing money on every biotech move he did.
That's another fact. That's also a trend.
Pepmoron r u crying? Don't! Stop it!
Just commit Apoptosis instead!